The therapeutic importance of understanding mechanisms of neuronal cell death in neurodegenerative disease

Molecular Neurodegeneration

Volumn 4, Issue 1, 2009, Pages

  Golde, Todd E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60849127580     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-4-8     Document Type: Article

References (26)

1. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. MS Forman JQ Trojanowski VM Lee, Nat Med 2004 10 10 1055 1063 10.1038/nm1113 15459709
2. Toxic proteins in neurodegenerative disease. JP Taylor J Hardy KH Fischbeck, Science 2002 296 5575 1991 1995 10.1126/science.1067122 12065827
3. Protein aggregation and neurodegenerative disease. CA Ross MA Poirier, Nat Med 2004 10 Suppl S10 17 10.1038/nm1066 15272267
4. Value of genetic models in understanding the cause and mechanisms of Parkinson's disease. DJ Moore TM Dawson, Curr Neurol Neurosci Rep 2008 8 4 288 296 10.1007/s11910-008-0045-7 18590612
5. Genetic neurodegenerative diseases: the human illness and transgenic models. DL Price SS Sisodia DR Borchelt, Science 1998 282 5391 1079 1083 10.1126/science.282.5391.1079 9804539
6. Selective loss of central cholinergic neurons in Alzheimer's disease. P Davies AJ Maloney, Lancet 1976 2 8000 1403 10.1016/S0140-6736(76)91936-X 63862
7. An update on the neurochemistry of Alzheimer disease. P Davies, Adv Neurol 1983 38 75 86 6137134
8. The neurochemistry of Alzheimer's disease and senile dementia. P Davies, Med Res Rev 1983 3 3 221 236 10.1002/med.2610030302 6136637
9. Aromatic amino acids and modification of parkinsonism. GC Cotzias MH Van Woert LM Schiffer, N Engl J Med 1967 276 7 374 379 5334614
10. Modification of Parkinsonism chronic treatment with L-dopa. GC Cotzias PS Papavasiliou R Gellene, N Engl J Med 1969 280 7 337 345 4178641
11. Neurodegeneration and neuroprotection in Parkinson disease. S Fahn D Sulzer, NeuroRx 2004 1 1 139 154 15717014 10.1602/neurorx.1.1.139
12. Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET. A Laihinen H Ruottinen JO Rinne M Haaparanta J Bergman O Solin M Koskenvuo R Marttila UK Rinne, J Neurol 2000 247 Suppl 2 II110 113 10991657
13. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease. S Thobois S Guillouet E Broussolle, Neurophysiol Clin 2001 31 5 321 340 10.1016/S0987-7053(01)00273-8 11817273
14. Axonal transport defects: a common theme in neurodegenerative diseases. S Roy B Zhang VM Lee JQ Trojanowski, Acta Neuropathol 2005 109 1 5 13 10.1007/s00401-004-0952-x 15645263
15. Oxidative stress in neurodegeneration: cause or consequence? JK Andersen, Nat Med 2004 10 Suppl S18 25 10.1038/nrn1434 15298006
16. Mitochondria take center stage in aging and neurodegeneration. MF Beal, Ann Neurol 2005 58 4 495 505 10.1002/ana.20624 16178023
17. Inflammation and Alzheimer's disease. H Akiyama S Barger S Barnum B Bradt J Bauer GM Cole NR Cooper P Eikelenboom M Emmerling BL Fiebich, Neurobiol Aging 2000 21 3 383 421 10.1016/S0197-4580(00)00124-X 10858586
18. The interplay between inflammation and neurodegeneration in CNS disease. MM Esiri, J Neuroimmunol 2007 184 1-2 4 16 10.1016/j.jneuroim.2006.11.013 17187866
19. Calcium and neurodegeneration. MP Mattson, Aging Cell 2007 6 3 337 350 10.1111/j.1474-9726.2007.00275.x 17328689
20. Autophagy and neurodegeneration: when the cleaning crew goes on strike. M Martinez-Vicente AM Cuervo, Lancet Neurol 2007 6 4 352 361 10.1016/S1474- 4422(07)70076-5 17362839
21. Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. SJ Berke HL Paulson, Curr Opin Genet Dev 2003 13 3 253 261 10.1016/S0959-437X(03)00053-4 12787787
22. Aggresomes, inclusion bodies and protein aggregation. RR Kopito, Trends Cell Biol 2000 10 12 524 530 10.1016/S0962-8924(00)01852-3 11121744
23. Conformational disease. RR Kopito D Ron, Nat Cell Biol 2000 2 11 E207 209 10.1038/35041139 11056553
24. Cell division in the CNS: protective response or lethal event in post-mitotic neurons? Y Yang K Herrup, Biochim Biophys Acta 2007 1772 4 457 466 17158035
25. Oxidative stress, cell cycle, and neurodegeneration. JA Klein SL Ackerman, J Clin Invest 2003 111 6 785 793 12639981
26. Tau suppression in a neurodegenerative mouse model improves memory function. K Santacruz J Lewis T Spires J Paulson L Kotilinek M Ingelsson A Guimaraes M DeTure M Ramsden E McGowan, Science 2005 309 5733 476 481 16020737 10.1126/science.1113694